Latest News

The third TransQST General Assembly meeting was held in BI premises in Ingelheim, Germany, on April 9th and 10th, 2019. During the first day parallel sessions of Organ WPs were organised. On the second day the consortium met at the plenary session for the WP updates and discussion on the next steps. The discussion at […]

The Research Division of Drug Discovery and Safety of the University of Leiden (UL) participates to TransQST consortium. Bob van de Water’s lab team has mined data of the TG-GATEs database on primary human hepatocytes, rat in vivo liver and kidney gene expression data and established WGCNA modules. These modules are available in an open […]

The Leiden University group for WP7 has been working in the last period to obtain in-depth insight into available data across species to support the cardiovascular hemodynamic modeling framework in order to identify gaps that we hope to fill (see figure). Furthermore, the group are currently running identifiability analyses to fully characterize the possible mode […]

TransQST young researchers presented two posters at the IMI 10th anniversary scientific symposium in October 2018 The Innovative Medicines Initiative celebrated its 10th anniversary in 2018, and several activities took place to mark the occasion, certainly the most prominent one was the Scientific Symposium held on 22nd– 23rd of October in Brussels. During the two […]

The second TransQST General Assembly meeting was held in Sanofi premises in Chilly Mazarin (Paris, France) on the 17th and 18th of October 2018. The consortium members had the opportunity to meet for the first time after the early review that took place in June 2018 and discuss the so-far progress. The TransQST project is […]